KIAA1656: A Potential Drug Target for Various Diseases (G85371)

Target Name: KIAA1656

NCBI ID: G85371

KIAA1656

Other Name(s): KIAA1656 protein

KIAA1656: A Potential Drug Target for Various Diseases

KIAA1656 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. Its full name is Kallikrein-related peptidase 6, and it is a member of the serine proteases enzyme family 16 (KIAA16) that is responsible for the breakdown of extracellular matrix (ECM) components. KIAA1656 has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and survival.

Recent studies have suggested that KIAA1656 may have potential as a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because the KIAA1656 gene has been implicated in the development and progression of several diseases, and its expression has been observed in the brains of individuals with certain diseases.

One of the reasons for the interest in KIAA1656 is its role in the regulation of the extracellular matrix (ECM). ECM is a complex structure that is composed of multiple components that help to maintain the mechanical stability of cells and support their growth and migration. The breakdown of ECM components by KIAA1656 has been shown to play a role in the regulation of cell adhesion and migration.

Studies have shown that KIAA1656 is involved in the regulation of cell-cell adhesion, which is the process by which cells stick together to form tissues and organs. In addition, KIAA1656 has been shown to be involved in the regulation of cell migration, which is the process by which cells move from their place of origin to their destination.

KIAA1656 has also been shown to be involved in the regulation of cell survival. Studies have shown that KIAA1656 can induce cell apoptosis (programmed cell death) in certain cell types, which is a natural process that helps to remove damaged or dysfunctional cells from the body. This process is important for maintaining tissue homeostasis and has been implicated in the development and progression of certain diseases.

In addition to its role in cell regulation, KIAA1656 has also been shown to be involved in the regulation of inflammation. Studies have shown that KIAA1656 can contribute to the production of pro-inflammatory cytokines, which are molecules that play a key role in the regulation of immune responses and inflammation. This suggests that KIAA1656 may have potential as a therapeutic agent for diseases that are characterized by chronic inflammation.

The potential drug targeting of KIAA1656 is based on its ability to interact with several different proteins, including cell adhesion molecules, cell migration factors, and cytokines. These interactions may provide a target for small molecules that can modulate the activity of KIAA1656 and its downstream signaling pathways.

In conclusion, KIAA1656 is a protein that has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and survival. Its potential as a drug target or biomarker for various diseases makes it an attractive target for further research and development. Further studies are needed to fully understand the role of KIAA1656 in the regulation of cellular processes and its potential as a therapeutic agent.

Protein Name: KIAA1656 Protein

The "KIAA1656 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA1656 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets